Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti ☰
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Malattie da Hantavirus

Bibliografia

Quali fonti bibliografiche considerare per le Malattie da Hantavirus?

Le informazioni contenute nella ricerca Pharmamedix dedicata alle malattie da Hantavirus sono state analizzate con riferimento alle seguenti fonti.

  1. Bradfute S.B. et al., J. Gen. Virol., 2024, 105 (4), 001975.

  2. Centers for Disease Control and Prevention - CDC, Hantavirus Prevention, 2024 https://www.cdc.gov/hantavirus/prevention/index.html (accesso: Maggio 2026).

  3. Chapman L.E. et al., Antivir. Ther., 1999, 4 (4), 211.

  4. Depypere M. et al., Viruses, 2020, 12 (2), 226.

  5. Engdahl T.B. et al., Cell Rep., 2021, 35 (5), 109086.

  6. Erdin M. et al., Euro. Surveill., 2023, 28 (40), 2300054.

  7. European Centre for Disease Prevention and Control – ECDC, Hantavirus infection – Annual Epidemiological Report for 2023, 2025, disponibile su https://www.ecdc.europa.eu/sites/default/files/documents/HANTA_AER_2023.pdf (accesso: maggio 2026).

  8. Fabbri D. et al., One Health Outlook, 2025, 7 (1), 15.

  9. Gavrilovskaya I. et al., J. Virol., 2010, 84 (9), 4832.

  10. Guimarães J.P.T. et al., Diagn. Microbiol. Infect. Dis., 2024, 110 (4), 116521.

  11. Gupta M. et al., JSDR, 2024, 9 (5), 1504 https://www.ijsdr.org/papers/2405198.pdf (accesso: maggio 2026).

  12. Hammerbeck C.D., Hooper J.W., J. Virol., 2011, 85 (19), 9929.

  13. Hamre H.J. et al., Syst. Rev., 2023, 12 (1), 191.

  14. Hooper J.W. et al., Clin. Microbiol. Infect., 2014, 20 Suppl 5, 110.

  15. Jacob A.T. et al., Biology (Basel), 2023, 12 (11), 1413.

  16. Jiang H. et al., Front. Cell. Infect. Microbiol., 2016, 6,1.

  17. Jonsson C.B. et al., Clin. Microbiol. Rev., 2010, 23 (2), 412.

  18. Jung J. et al., J. Infect. Dis., 2018, 217 (9), 1417.

  19. Klempa B., Clin. Microbiol. Infect., 2009, 15 (6), 518.

  20. Kruger D.H. et al., J. Clin. Virol., 2015, 64, 128.

  21. Leopardi S. et al., Viruses, 2022, 14 (6), 1241.

  22. Li Z. et al., Front. Pharmacol., 2021, 12, 745646.

  23. Li R. et al., J. Med. Virol., 2023, 95 (1), e28339.

  24. Lu W. et al., Front. Microbiol., 2024, 15, 1329683.

  25. MacNeil A. et al., Emerg. Infect. Dis., 2011, 17 (7), 1195.

  26. Martinez-Valdebenito C. et al., Emerg. Infect. Dis., 2014, 20 (10), 1629.

  27. Masci Walter, Omeopatia - Tradizione e attualità, 2003, Tecniche Nuove.

  28. Mayor J et al., Microorganisms, 2021, 9 (6), 1306.

  29. Mertz G.J. et al., Clin. Infect. Dis., 2004, 39 (9), 1307.

  30. Milholland M.T. et al., Viruses, 2019, 11 (7), 671.

  31. Mittler E. et al., Adv. Virus Res., 2019, 104, 185.

  32. Moreli M.L. et al., Virusdisease, 2014, 25 (3), 385.

  33. Mocanu A. et al., Viruses, 2023, 15 (4), 872.

  34. Noack D. et al., Front. Cell . Infect. Microbiol., 2020, 10, 399.

  35. Nunes B.T.D. et al., PLoS Negl Trop. Dis., 2019, 13 (12), e0007884.

  36. Pal M., Gutama K.P., Am. J. Infect. Dis. Microbiol., 2024, 12 (1), 19.

  37. Paulsen G.C. et al., J. Infect. Dis., 2023, 229 (1), 30.

  38. Perera W.P.R.T. et al., Biomed. Res, Int., 2021, 2021, 7872406.

  39. Romeo M.A. et al., Viruses, 2025, 17 (5), 622.

  40. Shen S-M., Xia W-Q., Zhong Xi Yi Jie He Xue Bao, 2005.

  41. Song J.Y. et al., Vaccine, 2016, 34 (10), 1289.

  42. Terças-Trettel A.C.P. et al., Rev. Inst. Med. Trop. Sao Paulo, 2019, 61, e65.

  43. Thorp L. et al., Pediatrics, 2023, (1), 57.151 (4), e2022059352.

  44. Tian H., Stenseth N.C., PLoS Negl. Trop. Dis., 2019, 13 (2), e0006901.

  45. Tkachenko E. et al., Viruses, 2025, 17 (4), 578.

  46. Toledo J. et al., J. Infect. Dis., 2022, 226 (8), 1362.

  47. Tortosa F. et al., BMJ Open, 2026, 16 (1), e096313.

  48. Vaheri A. et al., Nat. Rev. Microbiol., 2013, 11 (8), 539.

  49. Valenzuela G. et al., Viruses, 2025, 17 (9), 1241.

  50. Vapalahti O. et al., Lancet Infect. Dis., 2003, 3 (10), 653.

  51. Vial P.A. et al., Clin. Infect. Dis., 2013, 57 (7), 943.

  52. Vial P.A. et al., Lancet Infect. Dis., 2023, 23 (9), e371.

  53. Wang Y.X.G. et al., Proc. Biol. Sci., 2023, 290 (1996), 20222470.

  54. Wernly J.A. et al., Eur. J. Cardiothorac. Surg., 2011, 40 (6), 1334.

  55. World Health Organisation - WHO, 1993, Research guidelines for evaluating the safety and efficacy of herbal medicines.

  56. Yang J-X. et al., Viruses, 2025, 17 (7), 916.

  57. Yao H., McDonald E.G., CMAJ, 2016, 188 (17-18), E528.

  58. Zakaryan H. et al., Arch. Virol., 2017, 162 (9), 2539.

  59. Zheng Y. et al., Infect. Dis. (Lond), 2018, 50 (1), 21.

 

;